Pervasis pervasistx.com


Public lists: Pharma Startups (4733)

Pervasis Therapeutics, Inc. is developing biologically active therapeutics to regulate vascular repair and restore blood flow to critical organs and vasculature. The company's flagship product, Vascugel, is a cell-based therapeutic matrix developed to reestablish healthy vasculature after vascular injury. Per the company, Vascugel has the capability to be delivered in both open surgical and minimally invasive procedures. Pervasis is also exploring broader indications in non-vascular applicatio...Show all

Pervasis Therapeutics, Inc. is developing biologically active therapeutics to regulate vascular repair and restore blood flow to critical organs and vasculature. The company's flagship product, Vascugel, is a cell-based therapeutic matrix developed ...Show all

Company (Alive / Active)

Phone: 617-621-3407

Fax:

One Kendall Square
Building 600 1st Floor
Cambridge, 02139
Massachusetts, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Pervasis $39.7M Sep 9, 2009
See all 15 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Pervasis Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 5 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors

Q Therapeutics

Salt Lake City, Utah, United States
Alive / ActiveQ Therapeutics, Inc. is developing glial cell-based therapeutic products for central nervous system disorders in which a disease or injury inhibits normal myelin growth and enzyme performance.Login to see details

CoDa Therapeutics

San Diego, California, United States
Alive / ActiveCoDa Therapeutics is a clinical stage biotechnology company focused on developing targeted therapies that address major unmet medical needs in inflammation, wound-healing and tissue repair. The company is developing a new field of science known as gap junction modulation, using a new class of therapeutics that can modulate wound responses and reduce inflammation. CoDa has two open INDs and has completed multiple Phase 1 and Phase 2 trials in both skin and eye, including Investigator-Initiated st...Show allLogin to see details
See all 15 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)